Teva Pharmaceutical Industries Ltd (ADR) TEVA shares are trading lower by $2.30 (6.5 percent) at $34.74 in Tuesday's session.
Although the company confirmed FY 2016 guidance, the departure of president and CEO of global generics, Siggi Olafsson, may indicate more problems at the generic drug-maker.
The issue, which has already been hit hard as part of the overall rout in the sector, is off by 47 percent from its December 31, 2015 close of $65.64.
Following a lower open, it managed a brief rally but found sellers ahead of the lower part of Monday's range ($36.40), only reaching $35.95 before continuing it move lower.
It went on to make new lows for the day and isn't far off the current one at $34.58. That marks the lowest level for the issue since March 2007, when it bottomed at $34.25.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.